Can Treatable Traits Be the Approach to Addressing the Complexity and Heterogeneity of COPD?

References

• Barrecheguren M, Miravitlles M. COPD heterogeneity: implications for management. Multidiscip Respir Med. 2016;11:14. doi:10.1186/s40248-016-0053-4
   PubMed Web of Science ®Google Scholar
• The Lancet. Complexities of care in COPD. Lancet. 2017;389(10069):574. doi:10.1016/S0140-6736(17)30327-6
   Web of Science ®Google Scholar
• Agusti A. The path to personalised medicine in COPD. Thorax. 2014;69(9):857–864. doi:10.1136/thoraxjnl-2014-205507
   PubMed Web of Science ®Google Scholar
• Woodruff PG, Agusti A, Roche N, Singh D, Martinez FJ. Current concepts in targeting chronic obstructive pulmonary disease pharmacotherapy: making progress towards personalised management. Lancet. 2015;385(9979):1789–1798. doi:10.1016/S0140-6736(15)60693-6
   PubMed Web of Science ®Google Scholar
• Castaldi PJ, Benet M, Petersen H, et al. Do COPD subtypes really exist? COPD heterogeneity and clustering in 10 independent cohorts. Thorax. 2017;72(11):998–1006. doi:10.1136/thoraxjnl-2016-209846
   PubMed Web of Science ®Google Scholar
• Singh D, Roche N, Halpin D, Agusti A, Wedzicha JA, Martinez FJ. Current controversies in the pharmacological treatment of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2016;194(5):541–549. doi:10.1164/rccm.201606-1179PP
   PubMed Web of Science ®Google Scholar
• Cazzola M. Moving to a personalized approach in respiratory medicine. From academic research to regulatory intervention. Front Drug Saf Regul. 2021;1:752581. doi:10.3389/fdsfr.2021.752581
   Google Scholar
• Agusti A, Barnes N, Cruz AA, et al. Moving towards a treatable traits model of care for the management of obstructive airways diseases. Respir Med. 2021;187:106572. doi:10.1016/j.rmed.2021.106572
   PubMed Web of Science ®Google Scholar
• Cazzola M, Rogliani P, Barnes PJ, et al. An update on outcomes for COPD pharmacological trials: a COPD investigators report - reassessment of the 2008 American Thoracic Society/European Respiratory Society statement on outcomes for COPD pharmacological trials. Am J Respir Crit Care Med. 2023;208(4):374–394. doi:10.1164/rccm.202303-0400SO
   PubMedGoogle Scholar
• Cazzola M, Calzetta L, Rogliani P, Matera MG. The challenges of precision medicine in COPD. Mol Diagn Ther. 2017;21(4):345–355. doi:10.1007/s40291-017-0266-z
   PubMed Web of Science ®Google Scholar
• Agustí A, Anzueto A, Celli BR, et al. GOLD 2023 executive summary: responses from the GOLD scientific committee. Eur Respir J. 2023;61(6):2300616. doi:10.1183/13993003.00616-2023
   PubMed Web of Science ®Google Scholar
• Cazzola M, Blasi F. There is still no established and accepted definition of COPD. Respir Med. 2023;214:107262. doi:10.1016/j.rmed.2023.107262
   PubMed Web of Science ®Google Scholar
• Ananth S, Hurst JR. ERJ advances: state of the art in definitions and diagnosis of COPD. Eur Respir J. 2023;61(4):2202318. doi:10.1183/13993003.02318-2022
   PubMed Web of Science ®Google Scholar
• van Zelst CM, Goossens LMA, Witte JA, et al. Stratification of COPD patients towards personalized medicine: reproduction and formation of clusters. Respir Res. 2022;23(1):336. doi:10.1186/s12931-022-02256-7
   PubMed Web of Science ®Google Scholar
• McDonald VM, Fingleton J, Agusti A, et al. Treatable traits: a new paradigm for 21st century management of chronic airway diseases: treatable traits down under international workshop report. Eur Respir J. 2019;53(5):1802058. doi:10.1183/13993003.02058-2018
   PubMed Web of Science ®Google Scholar
• Agusti A, Bel E, Thomas M, et al. Treatable traits: toward precision medicine of chronic airway diseases. Eur Respir J. 2016;47(2):410–419. doi:10.1183/13993003.01359-2015
   PubMed Web of Science ®Google Scholar
• Duszyk K, McLoughlin RF, Gibson PG, McDonald VM. The use of treatable traits to address COPD complexity and heterogeneity and to inform the care. Breathe. 2021;17(4):210118. doi:10.1183/20734735.0118-2021
   Web of Science ®Google Scholar
• Cardoso J, Ferreira AJ, Guimarães M, Oliveira AS, Simão P, Sucena M. Treatable traits in COPD - A proposed approach. Int J Chron Obstruct Pulmon Dis. 2021;16:3167–3182. doi:10.2147/COPD.S330817
   PubMed Web of Science ®Google Scholar
• Wang Z, Locantore N, Haldar K, et al. Inflammatory endotype-associated airway microbiome in chronic obstructive pulmonary disease clinical stability and exacerbations: a multicohort longitudinal analysis. Am J Respir Crit Care Med. 2021;203(12):1488–1502. doi:10.1164/rccm.202009-3448OC
   PubMed Web of Science ®Google Scholar
• Chotirmall SH, Bogaert D, Chalmers JD, et al. Therapeutic targeting of the respiratory microbiome. Am J Respir Crit Care Med. 2022;206(5):535–544. doi:10.1164/rccm.202112-2704PP
   PubMed Web of Science ®Google Scholar
• Segal LN, Huang YJ. Crossing kingdoms: host-microbial endotyping and the quest to understand treatable traits in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2021;203(12):1447–1448. doi:10.1164/rccm.202101-0169ED
   PubMed Web of Science ®Google Scholar
• Agustí A, Rapsomaniki E, Beasley R, et al. Treatable traits in the NOVELTY study. Respirology. 2022;27(11):929–940. doi:10.1111/resp.14325
   PubMed Web of Science ®Google Scholar
• Agusti A, Gibson PG, McDonald VM. Treatable traits in airway disease: from theory to practice. J Allergy Clin Immunol Pract. 2023;11(3):713–723. doi:10.1016/j.jaip.2023.01.011
   PubMed Web of Science ®Google Scholar
• Marques A, Souto-Miranda S, Machado A, et al. COPD profiles and treatable traits using minimal resources: identification, decision tree and stability over time. Respir Res. 2022;23(1):30. doi:10.1186/s12931-022-01954-6
   PubMed Web of Science ®Google Scholar
• Souto-Miranda S, van ‘t Hul AJ, Vaes AW, et al. Differences in pulmonary and extra-pulmonary traits between women and men with chronic obstructive pulmonary disease. J Clin Med. 2022;11(13):3680. doi:10.3390/jcm11133680
   PubMed Web of Science ®Google Scholar
• Sarwar MR, McDonald VM, Abramson MJ, McLoughlin RF, Geethadevi GM, George J. Effectiveness of Interventions targeting treatable traits for the management of obstructive airway diseases: a systematic review and meta-analysis. J Allergy Clin Immunol Pract. 2022;10(9):2333–2345. doi:10.1016/j.jaip.2022.05.012
   PubMed Web of Science ®Google Scholar